Specialty Pharma Journal Specialty, Precision & Technology
Walter and Eliza Hall Institute researchers have revealed for the first time the three-dimensional molecular ‘map’ of a protein that has been pinpointed as a driver of many types of cancers. The unprecedented view of the protein doublecortin kinase like domain 1 (DCLK1) could provide clues to how it contributes …
Tag Archives: Walter and Eliza Hall Institute
August, 2016
June, 2016
-
20 June
‘Holy Grail’ of Breast Cancer Prevention in High-Risk Women May be in Sight
Australian researchers have discovered that an existing medication could have promise in preventing breast cancer in women carrying a faulty BRCA1 gene. People who carry a faulty BRCA1 gene are at high risk of developing aggressive breast cancer. Currently many women with a gene mutation choose surgical removal of their …